R. Coleman

Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults

J. Kahn, P. Barditch-Crovo, A. Collier, 2001, Antimicrobial Agents and Chemotherapy.

Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers.

J. Kahn, K. Steimer, C. Dekker, 1994, The Journal of infectious diseases.

Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.

M. Schambelan, M. Feinberg, D. Chernoff, 1997, The Journal of infectious diseases.

A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia.

B. Dong, L. Gee, R. Coleman, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infection.

L. Sheiner, M. Jacobson, J. Mandema, 1996, The Journal of infectious diseases.

Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine

K. K. Lai, D. Katzenstein, M. Hirsch, 1995 .

Off-label drug use in human immunodeficiency virus disease.

E. Charlebois, D. Abrams, C. Brosgart, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Clinical experience and choice of drug therapy for human immunodeficiency virus disease.

K. Stephenson, D. Abrams, D I Abrams, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID mice.

J. Kahn, H. Gendelman, J. Talmadge, 1999, Vaccine.